Compare JBL & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBL | WAT |
|---|---|---|
| Founded | 1966 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | 17.4B |
| IPO Year | 1993 | 1995 |
| Metric | JBL | WAT |
|---|---|---|
| Price | $211.78 | $398.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $228.78 | ★ $382.14 |
| AVG Volume (30 Days) | ★ 1.1M | 616.8K |
| Earning Date | 12-17-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | N/A | ★ 3.82 |
| EPS | 5.92 | ★ 10.88 |
| Revenue | ★ $29,802,000,000.00 | $3,105,638,000.00 |
| Revenue This Year | $6.68 | $7.96 |
| Revenue Next Year | $5.65 | $6.32 |
| P/E Ratio | ★ $35.82 | $36.66 |
| Revenue Growth | 3.18 | ★ 6.90 |
| 52 Week Low | $108.66 | $275.05 |
| 52 Week High | $237.14 | $423.56 |
| Indicator | JBL | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 66.32 |
| Support Level | $189.60 | $371.57 |
| Resistance Level | $206.56 | $414.15 |
| Average True Range (ATR) | 7.75 | 9.98 |
| MACD | 1.19 | 0.04 |
| Stochastic Oscillator | 87.22 | 66.98 |
Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.The Company derives its revenue from providing comprehensive electronics design, production and product management services. It operates in two segments. The Electronics Manufacturing Services (EMS) segment, which is the key revenue driver, is focused on leveraging IT, supply chain design and engineering, technologies largely centered on core electronics. The Diversified Manufacturing Services (DMS) segment is focused on providing engineering solutions, with an emphasis on material sciences, technologies, and healthcare.
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.